Becton Dickinson & Co.: BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251¿

Hazard

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Details from the source

Reason for recall: There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process. Distribution: Domestic distribution nationwide. International distribution worldwide. Quantity: 2,363,168 total units Lot/code info: Catalog No. 231250 UDI-DI 00382902312505 Lots 1085656 1277053 1301694 1334451 2025108 2119580 2146396 3181025; Catalog No. 231251¿ UDI-DI 30382902312513 Lots 1007140 2146396 3181025 3234149 1085656 1210753 1277053 1301694 1334451 2025108 2119580

UPC codes

00382902312505, 30382902312513

Source

Official record: FDA (Device enforcement) ↗

Republished from the official source above; details can change — the source record controls.